Investment objective & strategy
As of Feb. 26, 2026 · prospectusObjective. The Fund seeks long-term capital appreciation.
Strategy. Under normal circumstances, the Fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP (Wellington Management). Wellington Managements investment process focuses on stock selection through fundamental analysis. The Fund takes a broad approach to investing in the health care sector. The Fund may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors. The Funds assets will be allocated across the major subsectors of the health care sector, with some representation typically maintained in each major subsector. The Fund will normally invest at least 25% of its total … Under normal circumstances, the Fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP (Wellington Management). Wellington Managements investment process focuses on stock selection through fundamental analysis. The Fund takes a broad approach to investing in the health care sector. The Fund may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors. The Funds assets will be allocated across the major subsectors of the health care sector, with some representation typically maintained in each major subsector. The Fund will normally invest at least 25% of its total assets, in the aggregate, in the following industries: pharmaceuticals and biotechnology, medical products and health services. The Fund may invest in securities of companies of any market capitalization.
Top holdings
As of Jan. 31, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| LILLY ELI and CO | — | $109.43M | 13.12% |
| MERCK & CO | — | $47.90M | 5.74% |
| JOHNSON&JOHNSON | — | $42.31M | 5.07% |
| UNITEDHEALTH GRP | — | $38.70M | 4.64% |
| ABBVIE INC | — | $32.05M | 3.84% |
| INTUITIVE SURGICAL INC | — | $29.28M | 3.51% |
| DANAHER CORP | — | $25.52M | 3.06% |
| ABBOTT LABS | — | $24.64M | 2.95% |
| EDWARDS LIFESCIENCES CORP | — | $23.60M | 2.83% |
| CENCORA INC | — | $22.69M | 2.72% |
Portfolio moves
Oct 31, 2025 → Jan 31, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| HARTFORD HEALTHCARE HLS FUND · HIAHX, HBGHX | 91% | 0.93% |
| VANGUARD HEALTH CARE FUND · VGHCX, VGHAX | 68% | 0.32% |
| State Street(R) Health Care Select Sector SPDR(R) ETF · XLV | 60% | 0.08% |
Advisers
| Firm | Role |
|---|---|
| Wellington Management Company LLP | Sub-adviser |
| Hartford Funds Management Company, LLC | Adviser |
Footnotes
- Expense ratio as of February 26, 2026, from the fund's prospectus.
- Net assets and holdings count as of January 31, 2026, from the fund's N-PORT filing.
- Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.